Health Canada drug identification number

DIN 02554429 — BAXDELA 450 MG

BAXDELA is a tablet of Delafloxacin marketed by XEDITON PHARMACEUTICALS INC. The full Delafloxacin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02554429
Brand name
BAXDELA
Active ingredient
Delafloxacin
Strength
450 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
XEDITON PHARMACEUTICALS INC
Health Canada status
MARKETED
Drug class
Fluoroquinolone antibacterial

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Delafloxacin products

DINBrandStrengthFormManufacturerStatus
02554437 BAXDELA 300 MG POWDER FOR SOLUTION XEDITON PHARMACEUTICALS INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.